{"id":"W6977161993","doi":"10.6084/m9.figshare.24070298","title":"Additional file 1 of Updated overall survival from the MONALEESA-3 trial in postmenopausal women with HR+/HER2− advanced breast cancer receiving first-line ribociclib plus fulvestrant","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Fulvestrant; Placebo; Adverse effect; Overall survival; Postmenopausal women; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002175296,0.001101328,0.001841303,0.001578403,0.0006894433,0.001592744,0.001407259,0.001118457,0.7533882],"category_scores_gemma":[0.02657525,0.00064619,0.00126794,0.003453417,0.0002394475,0.001956158,0.0008125989,0.001139475,0.07668195],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001149925,"about_ca_system_score_gemma":0.001857479,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004268662,"about_ca_topic_score_gemma":0.009772864,"domain_scores_codex":[0.9986274,0.0003333694,0.0003155971,0.0002642867,0.0002758521,0.0001835014],"domain_scores_gemma":[0.9830436,0.0111402,0.002525148,0.0009797746,0.001849752,0.0004615002],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.003313744,0.0001420527,0.003582288,0.009549073,0.00036082,0.00008011648,0.00005857138,0.001022844,0.000124747,0.0010667,0.9662908,0.01440822],"study_design_scores_gemma":[0.08096071,0.002328323,0.08039887,0.01329775,0.002326703,0.001021899,0.0003422996,0.005139104,0.001075621,0.01956956,0.7932256,0.0003135736],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"dataset","genre_gemma":"dataset","genre_scores_codex":[0.0002830678,0.00006745453,0.0001460553,0.0001019119,0.00001882969,0.0002058253,0.9977743,0.0001017582,0.001300728],"genre_scores_gemma":[0.0201312,0.0004534647,0.002160131,0.001146871,0.0002447997,0.007041027,0.9529701,0.0003941106,0.01545816],"genre_candidate":"dataset","genre_consensus":"dataset","teacher_disagreement_score":0.7533882,"threshold_uncertainty_score":0.3517618,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02565653570190988,"score_gpt":0.2702826857817846,"score_spread":0.2446261500798747,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}